Skip to main content
Clinical Trials/NCT05484726
NCT05484726
Completed
N/A

Maternal Role in Sensory-motor Stimulation for Oral Feed Establishment in Preterm Neonates: MSMS Trial

Fatima Memorial Hospital1 site in 1 country130 target enrollmentMarch 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Preterm Birth
Sponsor
Fatima Memorial Hospital
Enrollment
130
Locations
1
Primary Endpoint
Transition Time to Full Oral Feeding
Status
Completed
Last Updated
last year

Overview

Brief Summary

Hypothesis

Preterm babies who receive sensory motor stimulation from their mothers as compared to trained nurses will

  1. Start taking oral feed at the same time as compared to control group
  2. Take the same amount of milk at the commencement of oral feeding
  3. Take milk with equal efficiency
  4. Not face more adverse effects

Detailed Description

Aim To determine the maternal role in sensory-motor stimulation for oral feed establishment in preterm neonates Objective 1. Determine the effect of sensory-motor stimulation offered by the mother on the onset of oral feeding 2. Efficiency of mother-mediated stimulation techniques on oral feeding as compared to trained nurses 3. Study maternal role in the establishment of oral feed Hypothesis Preterm babies who receive sensory motor stimulation from their mothers as compared to trained nurses will 1. Start taking oral feed at the same time frame as compared to the control group 2. Take the very same amount of milk at the commencement of oral feeding 3. Take milk with equal efficiency 4. There is no extra burden of adverse effects Data Collection All on going and related trials for this intervention shall be registered in the ClinicalTrials.gov. Study shall be conducted after ethical approval from IRB. All participants shall be enrolled after written informed consent from mothers after approval from attending neonatologist (annexure 2). All relevant maternal and neonatal data shall be collected on a specially designed proforma (annexure 3) with following details 1. Part 1: Maternal demographic and clinical data (age, parity, educational qualification, residence, previous preterm baby, job status, diabetes, hypertensive disorders, chronic ailment, multifetal gestation 2. Part 2: Neonatal demographic data (gender, gestation age, birth weight, growth centiles, diagnosis, APGAR score, noninvasive (NIV) and invasive ventilation with duration, caffeine, days taken for establishment of gavage feeding, age, and weight at commencement of intervention, any other complication during study) 3. Part 3: Neonatal feeding physiological measurements (SpO2, respiratory rate, heart rate before and after feeding, daily weight gain, type of milk offered) 4. Part 4: Oral feeding skill (OFS) assessment adapted from the model presented by Lau and Smith (p). All parameters shall be recorded twice a day for D1, D2, and D3 separately. It includes * Total volume prescribed (ml) * Total volume has taken during feeding (ml) * Volume has taken during the first 5 min of feeding (ml) * Duration of oral feeding (min) * Overall transfer (OT %) volume taken/total volume prescribed * Proficiency(PRO%) volume taken during the first 5 min/total volume prescribed * Rate of transfer (RT) ml/min * SSB (Suck Swallow Breaths) coordination * Adverse events (cough, fatigue) * According to this oral feeding ability can be classified into four levels depending upon the level of maturity in ascending order as follows: * Level 1: PRO \< 30% and RT \< 1.5 ml/min * Level 2: PRO \< 30% and RT ≥ 1.5 ml/min * Level 3: PRO ≥ 30% and RT \< 1.5 ml/min * Level 4: PRO ≥ 30% and RT ≥ 1.5 ml/min

Registry
clinicaltrials.gov
Start Date
March 1, 2022
End Date
September 6, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rafia Gul

Assistant Professor

Fatima Memorial Hospital

Eligibility Criteria

Inclusion Criteria

  • All preterm of gestation age 28 to 34weeks
  • Haemodynamically stable
  • Established full Gavage feed
  • No respiratory distress
  • No need for respiratory support except LFNC
  • Do not receive any kind of analgesics

Exclusion Criteria

  • Syndromic babies /genetic disorders
  • Haemodynamically unstable babies including IVH (grade III \& IV), hemodynamically significant PDA on treatment, NEC(stage III)
  • Major malformations
  • Cleft lip and palate
  • Anemia requiring blood transfusion

Outcomes

Primary Outcomes

Transition Time to Full Oral Feeding

Time Frame: Expected time of oral feed establishment

Time interval between commencement of perioral sensory stimulation on D1 to establishment of full oral feed in both groups. It was done daily till 14th day of perioral sensory motor stimulation. Transition time to full oral feeding was the day at which baby was able to take oral feed of volume of 120-140ml/kg/day.

Improvement (Change) in Efficiency in Oral Feed Establishment

Time Frame: For record purpose in this study results, efficacy level was noted as L4 on the following days D1, D2, D3, D5, D7 and D14

According to this efficiency in oral feed establishment in terms of amount and time is determined for the intervention group vs the control group. It can be classified into four levels depending upon the level of maturity in ascending order as follows: * Level 1: PRO \< 30% and RT \< 1.5 ml/min * Level 2: PRO \< 30% and RT ≥ 1.5 ml/min * Level 3: PRO ≥ 30% and RT \< 1.5 ml/min * Level 4: PRO ≥ 30% and RT ≥ 1.5 ml/min For all neonates, efficacy was measured at 11.00 am and 5.00 pm following sensory motor stimulation for both groups till achievement of full oral feed.

•Adverse Outcome Monitoring

Time Frame: Adverse events were noted on D1, D2,D3,D5,D7 and D14

monitor for any adverse events like cough, breath holding, chocking, aspiration, tachycardia, and or bradycardia with 1. stimulation 2. feed Adverse outcome monitoring as non-life threatening adverse events including cough, tachycardia HR 180-200/min, bradycardia HR120 - 100/min, , tachypnea RR 60 - 70/min while maintaining SpO2 of \>90% at room air

•Adverse Events Monitoring

Time Frame: Adverse events were noted on D1, D2,D3,D5,D7 and D14

monitor for any adverse events like cough, breath holding, chocking, aspiration, tachycardia, and or bradycardia with 1. stimulation 2. feed Adverse outcome monitoring as non-life threatening adverse events including cough, tachycardia HR 180-200/min, bradycardia HR120 - 100/min, , tachypnea RR 60 - 70/min while maintaining SpO2 of \>90% at room air

Secondary Outcomes

  • • Total Volume Taken During Each Feeding(It was noted on D1, D2, D3, D5, D7 and D14)
  • • Volume Taken During the First 5 Min of Feeding (ml) VT5(Volume taken during the first 5 min of feeding (ml) VT5 was measured on D1, D2, D3, D5, D7 and D14)
  • •Rate of Transfer (RT) ml/Min(RT was measured on D1, D2, D3, D5, D7 and D14)
  • • Overall Transfer (OT Percent) Volume Taken/Total Volume Prescribed(OT was measured on D1, D2, D3, D5, D7 and D14)
  • • Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume Prescribed(PRO % was measured on D1, D2, D3, D5, D7 and D14)
  • • Neonates Feeding With SSB Coordination(It was measured on D1, D2, D3, D5, D7 and D14)

Study Sites (1)

Loading locations...

Similar Trials